These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 12899739)

  • 1. Fluvoxamine-induced hyperglycaemia in a diabetic patient with comorbid depression.
    Oswald P; Souery D; Mendlewicz J
    Int J Neuropsychopharmacol; 2003 Mar; 6(1):85-7. PubMed ID: 12899739
    [No Abstract]   [Full Text] [Related]  

  • 2. EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin.
    Jakob F; Wolf J
    Pharmacopsychiatry; 2007 May; 40(3):129. PubMed ID: 17541891
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of fluvoxamine intoxication demonstrating nonlinear elimination pharmacokinetics.
    Spigset O; Ohman R
    J Clin Psychopharmacol; 1996 Jun; 16(3):254-5. PubMed ID: 8784660
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrocardiographic findings during extended clinical trials of fluvoxamine in depression: one years experience.
    Hochberg HM; Kanter D; Houser VP
    Pharmacopsychiatry; 1995 Nov; 28(6):253-6. PubMed ID: 8773292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful electroconvulsive therapy in major depression with fluvoxamine-induced bruxism.
    Miyaoka T; Yasukawa R; Mihara T; Shimizu Y; Tsubouchi K; Maeda T; Mizuno S; Uegaki J; Inagaki T; Horiguchi J; Tachibana H
    J ECT; 2003 Sep; 19(3):170-2. PubMed ID: 12972988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine-associated oscillopsia and a role for personalized medication dosing.
    Singman EL; Hocum B; Yohannan J; Pearson V
    Drug Metab Pers Ther; 2015 Dec; 30(4):271-5. PubMed ID: 26351962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis.
    Kamo T; Horikawa N; Tsuruta Y; Miyasita M; Hatakeyama H; Maebashi Y
    Psychiatry Clin Neurosci; 2004 Apr; 58(2):133-7. PubMed ID: 15009816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nefazodone-induced hypoglycemia in a diabetic patient with major depression.
    Warnock JK; Biggs F
    Am J Psychiatry; 1997 Feb; 154(2):288-9. PubMed ID: 9016286
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood glucose dysregulation with mianserin].
    Wolter-Henseler D
    Psychiatr Prax; 1996 Jul; 23(4):200. PubMed ID: 8927655
    [No Abstract]   [Full Text] [Related]  

  • 10. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.
    Suzuki Y; Fukui N; Sawamura K; Sugai T; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T
    J Clin Psychopharmacol; 2008 Jun; 28(3):325-8. PubMed ID: 18480690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant response and fluvoxamine plasma concentrations: a pilot study.
    Schwarzenbach F; Netillard C; Demoly P; Bisschop D; Limat S; Bouquet S; Vandel S; Bel AM; Woronoff-Lemsi MC
    Pharm World Sci; 2003 Feb; 25(1):27-9. PubMed ID: 12661474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe diurnal somnolence induced by fluvoxamine-lithium combination.
    Marchesi C; Paini M; Maggini C
    Pharmacopsychiatry; 2005 May; 38(3):145-6. PubMed ID: 15902588
    [No Abstract]   [Full Text] [Related]  

  • 13. Notes on the use of fluvoxamine as treatment of depression in HIV-1-infected subjects.
    Grassi B; Gambini O; Scarone S
    Pharmacopsychiatry; 1995 May; 28(3):93-4. PubMed ID: 7568371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluvoxamine and convulsive syncope: case report].
    Régina W; Vandel S
    Therapie; 1998; 53(5):504-5. PubMed ID: 9921046
    [No Abstract]   [Full Text] [Related]  

  • 15. Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report.
    Cayköylü A; Albayrak Y; Uğurlu GK; Ekinci O
    Acta Neurol Belg; 2011 Mar; 111(1):62-5. PubMed ID: 21510237
    [No Abstract]   [Full Text] [Related]  

  • 16. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.
    Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J
    World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study.
    Terra JL; Montgomery SA
    Int Clin Psychopharmacol; 1998 Mar; 13(2):55-62. PubMed ID: 9669185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maprotiline versus fluvoxamine: comparison of their effects on the hypothalamo-hypophyseal-thyroid axis].
    De Mendonça Lima CA; Vandel S; Bonin B; Bechtel P; Carron R
    Encephale; 1997; 23(1):48-55. PubMed ID: 9172968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal medicine in the treatment of fluvoxamine-induced nausea and dyspepsia.
    Yamada K; Kanba S; Yagi G; Asai M
    Psychiatry Clin Neurosci; 1999 Dec; 53(6):681. PubMed ID: 10687751
    [No Abstract]   [Full Text] [Related]  

  • 20. [A comparative clinical evaluation of the antidepressive activity of fluoxetine and fluvoxamine].
    Lopukhov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(4):53-7. PubMed ID: 9214192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.